Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate for Cocaine Dependence
NCT00385268Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Nov 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acamprosate in cocaine dependence, sponsored by University of Pennsylvania. Primary endpoint: Cocaine Use Over the Eight Week Trial at 8 weeks. Started Nov 2006; status: completed.
02
Drugs
acamprosate
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00385268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385268.